source
- BioMarin's rare disease therapy shows no clinical benefit in Phase 3 testBioMarin’s enzyme replacement therapy for a rare genetic disorder called ENPP1 deficiency delivered mixed results in a late-stage study. Patients with the condition don't produce enough of the ENPP…Endpoints · 2mo ago↗ source
- STAT+: 1 in 8 women drink during pregnancy. Experts dread the consequencesMore than 1 in 8 pregnant women report drinking. Doctors warn fetal alcohol disorders may be more common than many realize, perhaps more common than autism.STAT · 2mo ago↗ source
- Opinion: Britain embraces a Massachusetts experiment on tobacco regulation — just as the state might roll it backBritain embraces a Massachusetts experiment on tobacco regulation — just as the commonwealth might roll it back.